AI leaders like Demis Hassabis and Dario Amodei discuss AI's potential to transform medical science, contrasting with pharma caution.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AI leaders like Demis Hassabis and Dario Amodei discuss AI's potential to transform medical science, contrasting with pharma caution.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Demis Hassabis
British artificial intelligence researcher (born 1976)
-
AlphaFold
software by DeepMind that has predicated how every protein folds
Nothing else this week.
-
Dario Amodei
CEO and co-founder of Anthropic, Ph.D. Princeton University 2011
- Anthropic announced that it chose Nasdaq as its IPO venue, while also noting its business model includes revenue sharing with partners like Amazon.
- High-profile executives and financial leaders debated AI risks, with Nvidia CEO Huang countering extinction claims and Anthropic's Amodei warning of development slowdown.
-
Anthropic
American artificial intelligence corporation
Related events
- Anthropic and Meta are noted as key players in the scrutinized AI sector, with Dario Amodei leading Anthropic amid safety concerns.
- Legislators are expressing concern over AI existential risks amid a high-stakes AI race.
- Dario Amodei, CEO of Anthropic, noted that the current AI development landscape involves a competitive race with China, alongside the role of OpenAI.
- Anthropic leader Dario Amodei is active, while Andy Kim pushes for bipartisan bills protecting critical infrastructure, alongside President Trump's views on AI guardrails.
- Bill Gates, Donald Trump, and Dario Amodei warned about the potential risks of artificial intelligence, with Trump's orders evaluating AI company products.